Aridhia, Glencoe Software create data analysis products

Aridhia Informatics Ltd., a multidisciplinary health informatics company, recently partnered with Glencoe Software to create products to aid the development of personalized therapies and deliver improved patient outcomes.
Register for free to listen to this article
Listen with Speechify
0:00
1:00
GLASGOW, Scotland—Aridhia Informatics Ltd., amultidisciplinary health informatics company, recently partnered with GlencoeSoftware to create products to aid the development of personalized therapiesand deliver improved patient outcomes.
 
The partnership brings together Aridhia's capabilities in accessing,storing and analyzing healthcare information with Glencoe's expertise inmanaging, sharing and publishing large scientific datasets generated inlaboratories around the world.
 
Anticipating an increased focus on stratified medicine incoming years, the two companies will work together to create products for theinternational healthcare, life and biomedical science markets using real-worldclinical, genetic and research information.
 
As part of the agreement, Aridhia will make a majorinvestment in Seattle-based Glencoe to further accelerate its already rapidgrowth in these areas.
 
 
"Dundee is a great place for life sciences companies such asAridhia and Glencoe to do business," said Prof. Peter Downes, principal of theuniversity, in a statement. "Their collaboration here will create jobs andfurther strengthen our innovation economy. It is good news for Dundee and goodnews for Scotland." 
 
Aridhia Informatics is a joint venture between theUniversity of Dundee, NHS Tayside and Sumerian IT Analytics. Aridhia provides acombination of clinical expertise, academic excellence and high-performancecomputing experience to generate real-time information services that improvethe safety, quality and efficiency of healthcare.
 
Glencoe Software has developed technology platforms that arebased on open-source software built by the Open Microscopy Environment. Foundedin 2000, OME builds and releases software tools for the analysis of very largescientific image datasets. Its tools are used globally throughout the academicand commercial communities.

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.
Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.
Characterizing lipid nanoparticles for RNA therapeutic development
Integrated multiomics and advanced nanoparticle analytics are improving how researchers perform RNA delivery, increasing therapeutic success.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue